Defense collaboration Recent DoD contract win and ongoing nerve agent countermeasure development via a 6.5-year, $53 million engagement signals a strong defense sector opportunity. Target similar government and high-security programs that require advanced drug delivery and stability expertise.

Public and private partnerships Strategic partnerships with entities like Battelle and Federal Equipment Company indicate receptiveness to collaboration and outsourcing of development tasks. Explore co-development, scale-up, and rapid prototyping opportunities with research institutions and equipment suppliers serving pharma.

Early to late-stage support CMC Pharma serves programs from pre-formulation through FDA approval and commercial launch, suggesting cross-stage opportunities with biotech startups and established pharma seeking CDMO partnerships for formulation, analytical chemistry, stability, and device-enabled delivery systems.

Specialized delivery focus Expertise in polymeric controlled release, in situ forming gels, suspensions, and novel delivery systems positions the firm for clients needing advanced drug delivery solutions, including complex generics, biologics, and niche small-molecule programs.

Smaller firm agility With 11-50 employees and a flexible, experienced scientific team, the company can offer personalized CDMO services, rapid communication, and tailored development plans ideal for startups and mid-sized companies seeking dedicated development partners.